1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

"H. Lundbeck A/S: PharmaVitae Profile" is now available at Fast Market Research

New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research

 
PRLog - May 19, 2011 - Introduction

This analysis examines the historical and forecast performance for Lundbeck in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Lundbeck's strategic outlook across the next 6 years* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

Highlights

Strategic insight into the prospects for Lundbeck over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/158632_h_lundbeck_as_pharmavit...
------------------------------------------------------------

* Benchmark Lundbeck's performance against key rivals in the prescription pharmaceutical sector* Assess the company's position versus key rivals in its core CNS focus market* Analyze how Lundbeck has increasingly used externalization strategies to both boost R&D productivity and enhance its geographic footprint


Report Table of Contents:

TABLE OF CONTENTS
ABOUT DATAMONITOR HEALTHCARE
About the PharmaVitae team
Chapter 1 About this profile
PharmaVitae Explorer database
Chapter structure
Data sourcing
Chapter 2 Executive summary
Key findings
Prescription pharmaceutical sales and growth rate performance, 2003-15
Financial performance, 2003-15
Lundbeck: PharmaVitae forecasts at a glance
Strategic insight
SWOT analysis
Chapter 3 Quarterly update
Latest quarterly sales
Latest comment
Latest prescription pharma product news
Latest corporate news
Chapter 4 Company introduction
Key findings
Background
Key corporate developments
M&A history
Current corporate structure
Chapter 5 Company sales
Key findings
Prescription pharmaceutical sales and growth rate analysis, 2003-15
Product analysis
Therapy area analysis
Geographic analysis
Launch/core/expiry analysis
Molecule type analysis
Externalization analysis
Chapter 6 Company financials
Key findings
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2003-09
Operating costs and profit analysis
Chapter 7 Key products and competitors
Overview
Cipralex (including Lexapro royalties)
Ebixa
Chapter 8 Appendix
References
Abbreviations
Exchange rates
About Datamonitor
Datamonitor consulting
Disclaimer

TABLE OF TABLES
Table 1: Lundbeck - PharmaVitae forecasts at a glance
Table 2: Lundbeck quarterly sales ($m), Q309-Q310
Table 3: Lundbeck product portfolio overview ($m), 2003-09
Table 4: Lundbeck product portfolio overview ($m), 2009-15
Table 5: Lundbeck prescription pharmaceutical sales by therapy area ($m), 2009-15
Table 6: Lundbeck prescription pharmaceutical sales by geographic region ($m), 2009-15
Table 7: Lundbeck launch portfolio overview ($m), 2009-15
Table 8: Lundbeck core portfolio overview ($m), 2009-15
Table 9: Lundbeck expiry portfolio overview ($m), 2009-15
Table 10: Lundbeck prescription pharmaceutical sales by molecule type ($m), 2009-15
Table 11: Lundbeck prescription pharmaceutical sales by source ($m), 2009-15
Table 12: Total Lundbeck sales by business unit ($m), 2003-09
Table 13: Lundbeck operating revenue/cost analysis ($m), 2003-09
Table 14: Lundbeck operating cost ratio analysis (% of total revenues), 2003-09
Table 15: Lundbeck operating cost ratio analysis (% of total revenues), 2009-15
Table 16: Lundbeck operating revenue/cost analysis ($m), 2009-15
Table 17: Key products overview
Table 18: Cipralex: overview
Table 19: Cipralex: sales forecast ($m), 2008-14
Table 20: Ebixa: overview
Table 21: Ebixa: sales forecast ($m), 2009-15
Table 22: Exchange rates, 2010

TABLE OF FIGURES
Figure 1: The PharmaVitae Explorer
Figure 2: Lundbeck prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15
Figure 3: Lundbeck's financial performance ($m), 2003-15
Figure 4: Share of CNS market in 5EU and 'rest of world' by company (%), 2009-15
Figure 5: Lundbeck SWOT analysis
Figure 6: Lundbeck prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15
Figure 7: Key product sales ($m), 2003-15
Figure 8: Lundbeck key sales growth drivers and resistors ($m), 2003-09
Figure 9: Lundbeck key sales growth drivers and resistors ($m), 2009-15
Figure 10: Lundbeck prescription pharmaceutical sales by therapy area ($m), 2003-15
Figure 11: Lundbeck prescription pharmaceutical sales by geographic region ($m), 2003-15
Figure 12: Lundbeck launch/core/expiry configuration ($m), 2009-15
Figure 13: Lundbeck prescription pharmaceutical sales by molecule type ($m), 2003-15
Figure 14: Lundbeck prescription pharmaceutical sales by source ($m), 2003-15
Figure 15: Lundbeck operating revenue/cost analysis ($m), 2003-15

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment.  View more research from Datamonitor at http://www.fastmr.com/catalog/publishers.aspx?pubid=1002

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

--- End ---

Click to Share

Contact Email:
***@fastmr.com Email Verified
Source:Fast Market Research
Phone:1.800.844.8156
Zip:01267
Location:Massachusetts - United States
Industry:Medical, Research, Biotech
Tags:lundbeck, prescription, pharmaceutical, 2003-15, pharmavitae, 2003-09, molecule, therapy, revenuecost, cipralex
Shortcut:prlog.org/11498553
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share